These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Evaluation of greyhound susceptibility to malignant hyperthermia using halothane-succinylcholine anesthesia and caffeine-halothane muscle contractures. Cosgrove SB; Eisele PH; Martucci RW; Gronert GA Lab Anim Sci; 1992 Oct; 42(5):482-5. PubMed ID: 1460848 [TBL] [Abstract][Full Text] [Related]
7. [Mild variant of malignant hyperthermia following succinylcholine and halogenated agent exposure]. Fernández-García V; Bermejo MA; Vázquez C; Pereda MJ; Altarriba JM; Alvarez E Rev Esp Anestesiol Reanim; 1995 Nov; 42(9):401-2. PubMed ID: 8584782 [No Abstract] [Full Text] [Related]
8. Case of leptosuccin induced malignant hyperthermia in a patient with GIST of the rectum. Natasa N; Snezana P; Nemanja Z; Zoran K; Durasić L Acta Chir Iugosl; 2012; 59(2):121-3. PubMed ID: 23373371 [TBL] [Abstract][Full Text] [Related]
9. Malignant hyperthermia-like syndrome and carnitine palmitoyltransferase II deficiency with heterozygous R503C mutation. Hogan KJ; Vladutiu GD Anesth Analg; 2009 Oct; 109(4):1070-2. PubMed ID: 19762733 [TBL] [Abstract][Full Text] [Related]
10. Succinylcholine infusion associated with hyperthermia in ponies anesthetized with halothane. Hildebrand SV; Howitt GA Am J Vet Res; 1983 Dec; 44(12):2280-4. PubMed ID: 6660617 [TBL] [Abstract][Full Text] [Related]
11. Unexpected MH deaths without exposure to inhalation anesthetics in pediatric patients. Brandom BW; Muldoon SM Paediatr Anaesth; 2013 Sep; 23(9):851-4. PubMed ID: 23848295 [TBL] [Abstract][Full Text] [Related]
12. No response to trigger agents in a malignant hyperthermia-susceptible patient. Claxton BA; Cross MH; Hopkins PM Br J Anaesth; 2002 Jun; 88(6):870-3. PubMed ID: 12173209 [TBL] [Abstract][Full Text] [Related]
13. Succinylcholine in malignant hyperthermia: evaluation of a novel in vivo model. Metterlein T; Schuster F; Palmer E; Roewer N; Anetseder M Muscle Nerve; 2011 Aug; 44(2):213-6. PubMed ID: 21607984 [TBL] [Abstract][Full Text] [Related]
14. Malignant hyperthermia. Rosenberg H; Davis M; James D; Pollock N; Stowell K Orphanet J Rare Dis; 2007 Apr; 2():21. PubMed ID: 17456235 [TBL] [Abstract][Full Text] [Related]
15. Effects of droperidol, haloperidol and ketamine on halothane, succinylcholine and caffeine contractures: implications for malignant hyperthermia. Fletcher JE; Rosenberg H; Lizzo FH Acta Anaesthesiol Scand; 1989 Apr; 33(3):187-92. PubMed ID: 2728821 [TBL] [Abstract][Full Text] [Related]
16. Unusual response following use of succinylcholine in a horse anesthetized with halothane. Riedesel DH; Hildebrand SV J Am Vet Med Assoc; 1985 Sep; 187(5):507-8. PubMed ID: 4055481 [TBL] [Abstract][Full Text] [Related]
17. Malignant hyperthermia in a Greyhound. Bagshaw RJ; Cox RH; Knight DH; Detweiler DK J Am Vet Med Assoc; 1978 Jan; 172(1):61-2. PubMed ID: 624662 [TBL] [Abstract][Full Text] [Related]
18. Malignant hyperthermia during desflurane-succinylcholine anesthesia for orthopedic surgery. Garrido S; Fraga M; Martín MJ; Belda J Anesthesiology; 1999 Apr; 90(4):1208-9. PubMed ID: 10201695 [No Abstract] [Full Text] [Related]
19. The risk of malignant hyperthermia in children undergoing muscle biopsy for suspected neuromuscular disorder. Flick RP; Gleich SJ; Herr MM; Wedel DJ Paediatr Anaesth; 2007 Jan; 17(1):22-7. PubMed ID: 17184427 [TBL] [Abstract][Full Text] [Related]
20. Human malignant hyperthermia associated with desflurane anesthesia. Allen GC; Brubaker CL Anesth Analg; 1998 Jun; 86(6):1328-31. PubMed ID: 9620529 [No Abstract] [Full Text] [Related] [Next] [New Search]